Stryker proposes divesting total ankle, finger joint product — 4 details

Angie Stewart -   Print  |

Stryker proposed divesting certain assets in connection to its planned acquisition of Wright Medical, which is under review by the Federal Trade Commission, according to a filing with the Securities and Exchange Commission.

What you should know:

1. Stryker proposed a plan to divest its STAR total ankle replacement product plus related assets, as well as finger joint replacement products to Colfax Corporation/DJO Global.

2. The proposal requires regulatory approvals and the execution of definitive divestiture documents.

"There can be no assurance that the proposed divestiture will receive the necessary regulatory approvals or be consummated," the SEC filing said.

3. Stryker first announced plans to acquire Wright Medical, a device company focusing on orthopedic extremities and biologics, in November 2019.

4. The total enterprise value of the transaction would be about $5.4 billion, including equity and debt. 

More articles on devices:
Meet Elon Musk's surgical robot
Laser Spine Institute 18 months after closure — What happened to its $56M Tampa HQ?
Vertebral body tethering shows success in the treatment of scoliosis, study finds


© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers